Browse

You are looking at 81 - 90 of 307 items for :

  • Refine by Content Type: All x
Clear All Modify Search
Areeba Jawed

I am worried your brother might not be allowed to give you a kidney, Jose,” I said to my patient of 5 years while shifting my feet, nervous that my actions would give away the guilt that was suffocating me.

I had taken care of Jose throughout his journey with kidney disease, and he was now approaching the need for dialysis or transplantation.

Jose was accompanied by his Spanish-speaking brother, who looked bewildered as he read our faces. Fumbling with the contents of his wallet, he pointed to the heart on his driver’s license.

Unsure how to respond to this

Tod Ibrahim

Tod Ibrahim

Tod Ibrahim, ASN executive vice president, has been named president of the Council of Medical Specialty Societies (CMSS). His term took effect in November 2019.

“CMSS is uniquely positioned to help address pressing clinical topics, research-related issues, and educational topics common to its members,” Ibrahim said. “There is an opportunity to think creatively across specialties, and that was really appealing to me.”

Founded in 1965, CMSS provides an independent forum for the discussion by medical specialists of issues of national interest and mutual concern. The organization currently has 46 national medical society members representing more than 800,000 physicians.

Vivek Kumar and Vivekanand Jha

Asia is synonymous with diversity, which is reflected in the epidemiology of kidney diseases, especially acute kidney injury (AKI). In contrast to people in the industrialized developed countries, most Asian people, especially those living in rural areas with relatively limited access to healthcare, continue to bear a large burden of AKI. This condition develops in these communities secondary to locally prevalent health issues of public health importance.

The 0by25 Global Snapshot study by the International Society of Nephrology showed that 80% of the burden of AKI in low- and middle-income countries of Asia is community acquired. Community-acquired AKI (CA-AKI) predominantly

Bridget M. Kuehn

Undergoing home dialysis in a shared house with other patients of Māori or Pacific ethnicity without medical supervision provided patients with flexibility and support, and enabled them to overcome obstacles to home dialysis, according to a recent study.

New Zealand, where the study was conducted, has long embraced home dialysis. But not all patients are able to or want to do dialysis at home. To help meet their needs, an initiative launched in 2004 to set up community dialysis homes across the country where patients can go to dialyze on their own schedule. The local kidney societies own the homes

Karen Blum

About 15 years ago, nephrologist Sanjay Pandya, MD, noticed that his patients were facing difficulties understanding their kidney diseases, including what to eat or not eat, and what other care they needed. He thought that if there were a book that spelled everything out in a single source, it would be useful to his patients, and he could then reduce the amount of time he spent counseling about these topics.

So, in 2006, Pandya, who has a private practice in Gujarat, India, wrote a book, “Save Your Kidneys,” in his native Gujarati language. The 200-page text, given free to patients,

Children born to mothers with gestational or pregestational diabetes are at increased risk of developing cardiovascular disease (CVD) at follow-up through young adulthood, reports a study in the British Medical Journal.

The prevalence of CVD among children and young adults has increased in recent decades. Rates of pregestational and gestational diabetes have been rising as well; a growing body of evidence suggests that offspring of women with diabetes are at increased risk of metabolic syndrome and congenital heart disease. This population-based study sought to determine the extent to which exposure to maternal diabetes increases the lifetime risk of

A nationwide public awareness campaign to promote early detection, treatment, and management of kidney disease is launching in March 2020 in conjunction with National Kidney Month.

The campaign, called “Are You the 33%?” aims to engage every adult to learn more about their risk for kidney disease by taking a simple, one-minute online quiz at MinuteforYourKidneys.org.

One in three adults in the United States is at risk for kidney disease.

“Look around the next time you’re sitting in a school auditorium or even in a giant professional sports stadium; one-third of every adult in there with you is at risk

Michele H. Mokrzycki

In 2017, approximately 459,000 patients in the United States received in-center hemodialysis (HD), and more than 108,000 new patients began renal replacement with HD (1). HD catheters were the most common form of vascular access in new patients, accounting for 80% of all accesses. Therefore, more than 86,000 new HD patients began treatment with a catheter in 2017 (1). Among prevalent HD patients, catheter use was lower: approximately 20%. Unfortunately, catheter use in patients receiving both incident and prevalent HD has remained unchanged over the past 6 years.

Patients receiving in-center HD are a unique patient

Leveraging the Science of Learning to Elevate Your Teaching” was the topic of an inaugural faculty development workshop for medical educators at Kidney Week 2019. The workshop showcased high-yield strategies to optimize participants’ teaching, enhance the experience of learners, and translate teaching innovations into education scholarship for dissemination and academic credit. Advancing education in nephrology has long been a focus of ASN Past President Mark E. Rosenberg, MD, FASN.

Suzanne Norby, MD, FASN, chair of the ASN Continuous Professional Development Committee, and Melanie Hoenig, MD, developed and moderated the session, which featured a cast of education rock stars and provided

Richard Lafayette

This is a highly exciting year for nephrology. We will all need not only to watch but to participate in bringing about positive changes in healthcare for preventing and treating kidney diseases, hoping for strong support from the Advancing American Kidney Health initiative. One of the strongest reasons for enthusiasm, and one of the most important aspects, will be advancing clinical trials in nephrology.

Clinical trials are the lifeblood of advancing medicine. To truly improve kidney care, we must be able to subject our treatments to rigorous high-quality trials in the appropriate patients and to evaluate them for the appropriate